{
    "organizations": [],
    "uuid": "df97bf8e2c9f974702a72d2f879ed9d388c684ba",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-matinas-biopharma-reports-2017-fin/brief-matinas-biopharma-reports-2017-financial-results-idUSASC09TOY",
    "ord_in_thread": 0,
    "title": "BRIEF-Matinas Biopharma Reports 2017 Financial Results",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 26 (Reuters) - Matinas Biopharma Holdings Inc :\n* MATINAS BIOPHARMA REPORTS 2017 FINANCIAL RESULTS * MATINAS BIOPHARMA - ‍ENDED YEAR WITH CASH AND CASH EQUIVALENTS OF ABOUT $7.3 MILLION​\n* MATINAS BIOPHARMA HOLDINGS INC - BELIEVES THAT CASH ON HAND IS SUFFICIENT TO FUND OPERATIONS INTO SEPTEMBER 2018 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-27T04:57:00.000+03:00",
    "crawled": "2018-03-27T12:01:08.008+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "matinas",
        "biopharma",
        "holding",
        "inc",
        "matinas",
        "biopharma",
        "report",
        "financial",
        "result",
        "matinas",
        "biopharma",
        "year",
        "cash",
        "cash",
        "equivalent",
        "matinas",
        "biopharma",
        "holding",
        "inc",
        "belief",
        "cash",
        "hand",
        "sufficient",
        "fund",
        "operation",
        "september",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}